Company Overview
City of Hope is dedicated to delivering groundbreaking treatments to those who need them most. Since its founding in 1913, it has become one of the largest cancer research and treatment organizations in the United States, as well as a leading center for research on diabetes and other life-threatening diseases. City of Hope’s pioneering research has led to major medical advancements, including breakthrough cancer therapies, human synthetic insulin, and monoclonal antibodies.
At the heart of City of Hope is its independent, National Cancer Institute-designated comprehensive cancer center, which integrates cutting-edge research, patient care, academic training, and innovation. Its expanding national network includes a flagship campus in Los Angeles, clinical care locations across Southern California, a state-of-the-art cancer center in Orange County, and treatment facilities in Atlanta, Chicago, and Phoenix. Additionally, City of Hope’s affiliated organizations, including the Translational Genomics Research Institute and AccessHope™, further its mission of advancing scientific discoveries and improving patient outcomes.